MobiHealthNews

Study: Abbott’s FreeStyle Libre 14-day system cuts diabetes management costs

A new study published in US Endocrinology found Abbott’s continuous glucose monitoring system, the FreeStyle Libre, demonstrated significant cost savings for diabetic care compared to traditional ...
MobiHealthNews

Abbott finally gets FDA greenlight for FreeStyle Libre 2

This morning Abbott revealed that its much anticipated integrated continuous glucose monitoring system the FreeStyle Libre 2 is now FDA cleared for adults and kids over the age of 4 with diabetes. The ...
The American Journal of Managed Care

FreeStyle Libre CGM Sees Rising Use With Pharmacy Chain Distribution

When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to greater ...
BioWorld

Abbott stakes out lead in fingerstick-free CGM, hits 1M Freestyle Libre users

SAN FRANCISCO – Fingerstick-free continuous glucose monitors (CGMs) are a fast-growing segment, where Abbott has a first mover advantage. Dexcom Inc., of San Diego, gained its own label last year on ...
Medscape

FDA Clears Next-Generation Libre Glucose Monitor for Diabetes

The US Food and Drug Administration (FDA) has cleared the FreeStyle Libre 2 integrated continuous glucose monitoring (CGM) system for adults and children ages 4 years and older with diabetes. The ...
CNET

Abbott Warns Small Number of FreeStyle Libre 3 Sensors May Give Inaccurate Readings

Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's issuing a voluntary medical device correction for some of its FreeStyle ...
EurekAlert!

New data show Abbott's FreeStyle® Libre 14 day system significantly reduces costs associated with diabetes management and complications

Cost model data published in U.S. Endocrinology show for commercially-insured people with diabetes on intensive insulin therapy, using FreeStyle Libre technology costs 60% less compared to traditional ...
Nasdaq

Abbott's FreeStyle® Libre 2 iCGM System Now Available to Medicare Beneficiaries

- U.S. Centers for Medicare & Medicaid Services (CMS) reimbursement expands access of the FreeStyle Libre 2 system to Medicare patients[1] to better manage their diabetes - The FreeStyle Libre 2 ...
Forbes

2 Million Patients And Beyond: Abbott’s FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes

Pharmaceutical and med device giant Abbott (NYSE: ABT) said today that it had received approval from the Food and Drug Administration (FDA) for its next-generation integrated continuous glucose ...
Nasdaq

U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems

Abbott's world's leading1 and affordable2 integrated continuous glucose monitoring (iCGM) sensors are cleared for connectivity with automated insulin delivery (AID) systems in the U.S. Sensors also ...
Orlando Sentinel

Glucose Monitoring Just got Easier. Routine Fingersticks are Now a Thing of the Past.

If you are one of the 30 million Americans with diabetes, you know all too well that the painful routine of checking blood sugar levels has remained unchanged for decades. Prick your finger, drop ...